Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®
NCT01908192
Recruiting
The purpose of this study is to determine if NaBen® is a safe and effective add-on treatment for schizophrenia in adolescents.
Gender:
All
Ages:
Between 12 years and 17 years
Trial Updated:
09/10/2021
Locations: Precise Research Centers, Flowood, Mississippi
Conditions: Schizophrenia
Register for Updates
Cerebral Palsy Hip Outcomes Project - International Multi-centre Study
NCT01987882
Recruiting
The primary purpose of the project is to evaluate the effectiveness of different intervention strategies to prevent or relieve symptoms associated with hip instability in children with severe cerebral palsy, using the validated Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD©) questionnaire as the primary outcome measure of health-related quality of life for this population.
Gender:
All
Ages:
Between 2 years and 18 years
Trial Updated:
02/09/2021
Locations: Children's of Mississippi, Jackson, Mississippi
Conditions: Cerebral Palsy
Register for Updates
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis
NCT04718818
Recruiting
The present study D5272C00001 (Legacy # 3151-201-008) seeks to evaluate the efficacy and safety of brazikumab versus placebo in patients with moderately to severely active UC and will include assessments of clinical responses as demonstrated by improvement of symptoms and of colonic mucosal appearance as observed on endoscopy.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
01/19/2021
Locations: Research Site, Biloxi, Mississippi
Conditions: Ulcerative Colitis
Register for Updates
Primaquine Enantiomers in G6PD Deficient Human Volunteers
NCT04073953
Recruiting
This study is a single center, prospective, cross-over phase 1 trial. Eighteen subjects will be enrolled in the study evaluating the metabolism, pharmacokinetic behavior and tolerability of primaquine enantiomers and placebo over the course of 5 days.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
10/14/2020
Locations: University of Mississippi, University, Mississippi
Conditions: G6PD Deficiency
Register for Updates
VENOUS: A Translational Study of Enterococcal Bacteremia
NCT04410276
Recruiting
The purpose of this study is to assemble a multicenter prospective cohort of patients with enterococcal bloodstream infections (BSIs) to provide data on outcomes of patients with enterococcal BSIs for sample size calculations for future trials, as well as to characterize enterococcal isolates causing BSIs in order to comprehensively dissect the molecular epidemiology of infecting organisms for future studies.
Gender:
All
Ages:
18 years and above
Trial Updated:
05/26/2020
Locations: University of Mississippi Medical Center, Jackson, Mississippi
Conditions: Enterococcal Bacteremia
Register for Updates
Evaluation of a Mobile App to Promote Social Support for Oncology Patients
NCT04331678
Recruiting
Our study will evaluate patient and caregiver use of a new mobile application (app) to support patients undergoing chemotherapy treatment for cancer.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/31/2020
Locations: West Cancer Center, Southaven, Mississippi
Conditions: Chemotherapy Effect
Register for Updates
Starting Granulocyte Colony-Stimulating Factor at 1 Day vs 3 Days Following Chemotherapy in Pediatric Cancer Patients
NCT03823950
Recruiting
Chemotherapy places patients at an increased risk of infection. A medication called granulocyte colony-stimulating factor is given as a daily injection in order to help decrease the risk of infection. The purpose of this study is to determine the best time to begin granulocyte colony-stimulating factor while maintaining the same clinical benefits. The current study aims to fill these research gaps and address the general question: Can G-CSF safely be given 72 hours following the last day of chem... Read More
Gender:
All
Ages:
21 years and below
Trial Updated:
03/11/2020
Locations: Univeristy of Mississippi Medical Center, Jackson, Mississippi
Conditions: Granulocyte Colony-Stimulating Factor, Chemotherapy-induced Neutropenia, Chemotherapy-Induced Febrile Neutropenia, Pediatric Cancer
Register for Updates
Do AxoGuard Implants Decrease Shoulder Disability After Neck Dissections
NCT03941327
Recruiting
The purpose of this study is to determine whether Axoguard nerve protectors have a role in preventing shoulder disability and pain following spinal accessory nerve sparing neck dissections.
Gender:
All
Ages:
18 years and above
Trial Updated:
05/06/2019
Locations: University of Mississippi Medical Center, Jackson, Mississippi
Conditions: Spinal Accessory Nerve Injury, Cervical Lymphadenopathy
Register for Updates
Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care
NCT02832297
Recruiting
In this 12-month multi-center prospective, site-randomized, two-arm trial, approximately 318 biologic-naïve subjects with RA who are candidates for treatment intensification due to inadequate response to MTX monotherapy will be enrolled at up to 60 study sites.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
07/27/2018
Locations: North Mississippi Medical Center, Tupelo, Mississippi
Conditions: Arthritis, Rheumatoid
Register for Updates